BioBoard
•  Worms Therapy
•  New Cyberknife Clinical Training Center
•  Crop Biotechnology Knowledge Sharing
•  ISAAA's Fourth Knowledge Center in India

Industry Watch
•  Relenza Dispute between Biota & GSK
•  Bionomics Collaborates with Louisiana State University in Cancer Gene Therapy
•  Acyte and Serono Working on Cell Expression Technology
•  Rockeby Biomed Test SysCan3 on Newborns in US
•  Regenera Receives Human Ethics Approval for Visagen Phase III Trial
•  CyGenics and MCRI Collaborate in Stem Cell Expansion Trials
•  Antisense Therapeutics' MS Drug Enters Phase 2 Clinical Trials
•  Concerns over Impact of FTA on Pharma Industry
•  AstraZeneca Outlines Plan for Expansion of India-based Operations
•  Indian Drug Exports Likely to be Affected by New US Initiatives
•  Ranbaxy Seeking New CRO for Generic AIDS Drugs
•  Kyorin and Merck Collaborate in Antibiotics Research
•  Kyowa and AnalytiCon Succeeded on Molecule Search
•  Takeda Withdraws from Five Joint Ventures
•  Fujisawa's New Formulation Facilities Completed
•  Lion Takes On Chugai's OTC Drugs Business
•  Cancer Vac Commences Phase II Trial for Ovarian Cancer Treatment
•  Cordlife Secured US Defense Contract

Products/Services Highlight
•  Plant-made Plastics Took Eureka Prize

Research Findings
•  A Fishy Question of Paternity
•  Researchers Discover Protein for Combating Genetic Diseases
•  Scientists Developing World First Anti-Allergic DNA Vaccine for Asthma Prevention

Rules & Regulations
•  Pre-implantation Genetic Diagnosis of Embryos Demanded in Court
•  Amendments to Australian IP law with the US FTA

Agriculture
•  GM Cotton Benefits Environments
•  BAA: New Initiative to Promote GM Biotech

Alternative Medicine
•  Ranbaxy Develops a New Malaria Drug Using TCM
•  Herbal Remedies: Useful for Cancer Patients?

Commentaries & Analyses
•  The Impact of SARS on The Vietnam Economy
•  Deadline Strategies for US Patent Applications

General News
•  China Further Improves Rural Health System

Conference Calendar